Journal of Dementia
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Dement 8: 216.,
  • DOI: 10.4172/dementia.1000216

Case Report: Peripheral Neuropathy Associated with Isoniazid (INH) Use

Leonardo Ferrari* and Lorenzo Marino
Department of Neuroscience, San Raffaele Scientific Institute, Italy
*Corresponding Author : Leonardo Ferrari, Department of Neuroscience, San Raffaele Scientific Institute, Italy, Email: Leonardo.Fer@rari.it

Received Date: May 02, 2024 / Published Date: May 30, 2024

Abstract

Peripheral neuropathy is a rare but recognized complication associated with certain medications, including isoniazid (INH) used in tuberculosis (TB) treatment. We present the case of a 56-year-old male with a history of pulmonary TB treated with a regimen including INH, who developed progressive tingling and numbness in his feet and hands. Clinical examination and nerve conduction studies confirmed a diagnosis of isoniazid-induced peripheral neuropathy. Prompt cessation of INH and modification of TB therapy led to symptomatic improvement and stabilization of neuropathy. This case underscores the importance of considering medication-related neuropathies in patients on anti-TB regimens and the need for early recognition and management to prevent further neurological complications.

Citation: Ferrari L (2024) Case Report: Peripheral Neuropathy Associated with Isoniazid (INH) Use. J Dement 8: 216. Doi: 10.4172/dementia.1000216

Copyright: © 2024 Ferrari L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 314
  • [From(publication date): 0-2024 - Dec 22, 2024]
  • Breakdown by view type
  • HTML page views: 264
  • PDF downloads: 50
Top